Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Peripheral host T cells survive hematopoietic stem cell transplantation and promote graft-versus-host disease
Sherrie J. Divito, … , Frode L. Jahnsen, Thomas S. Kupper
Sherrie J. Divito, … , Frode L. Jahnsen, Thomas S. Kupper
Published June 9, 2020
Citation Information: J Clin Invest. 2020;130(9):4624-4636. https://doi.org/10.1172/JCI129965.
View: Text | PDF
Research Article Immunology

Peripheral host T cells survive hematopoietic stem cell transplantation and promote graft-versus-host disease

  • Text
  • PDF
Abstract

Graft-versus-host disease (GVHD) is a major cause of morbidity and mortality in hematopoietic stem cell transplantation (HSCT). Donor T cells are key mediators in pathogenesis, but a contribution from host T cells has not been explored, as conditioning regimens are believed to deplete host T cells. To evaluate a potential role for host T cells in GVHD, the origin of skin and blood T cells was assessed prospectively in patients after HSCT in the absence of GVHD. While blood contained primarily donor-derived T cells, most T cells in the skin were host derived. We next examined patient skin, colon, and blood during acute GVHD. Host T cells were present in all skin and colon acute GVHD specimens studied, yet were largely absent in blood. We observed acute skin GVHD in the presence of 100% host T cells. Analysis demonstrated that a subset of host T cells in peripheral tissues were proliferating (Ki67+) and producing the proinflammatory cytokines IFN-γ and IL-17 in situ. Comparatively, the majority of antigen-presenting cells (APCs) in tissue in acute GVHD were donor derived, and donor-derived APCs were observed directly adjacent to host T cells. A humanized mouse model demonstrated that host skin-resident T cells could be activated by donor monocytes to generate a GVHD-like dermatitis. Thus, host tissue-resident T cells may play a previously unappreciated pathogenic role in acute GVHD.

Authors

Sherrie J. Divito, Anders T. Aasebø, Tiago R. Matos, Pei-Chen Hsieh, Matthew Collin, Christopher P. Elco, John T. O’Malley, Espen S. Bækkevold, Henrik Reims, Tobias Gedde-Dahl, Michael Hagerstrom, Jude Hilaire, John W. Lian, Edgar L. Milford, Geraldine S. Pinkus, Vincent T. Ho, Robert J. Soiffer, Haesook T. Kim, Martin C. Mihm, Jerome Ritz, Indira Guleria, Corey S. Cutler, Rachael A. Clark, Frode L. Jahnsen, Thomas S. Kupper

×

Figure 3

Host T cells are present in gut during acute GVHD.

Options: View larger image (or click on image) Download as PowerPoint
Host T cells are present in gut during acute GVHD.
(A) Example of FISH-I...
(A) Example of FISH-IF from FFPE colon during acute GVHD. X chromosome, red; Y chromosome, green; CD3, blue; CD8, red; Hoechst nuclear stain, gray. Scale bar: 20 μm. Blue staining indicates CD4+ T cells (CD3+CD8–), whereas pink staining (mixed blue and red) indicates CD3+CD8+ T cells. White arrows point to donor (XX) T cells; yellow arrows point to recipient (XY) T cells. (B) Percentage of host gut T cell chimerism in acute GVHD. Red squares, myeloablative-conditioned patients; solid black circles, nonmyeloablative-conditioned patients; open black circles, breakdown of nonmyeloablative conditioning regimens. Black lines indicate median. Mann-Whitney U test, 2-tailed, myeloablative vs. nonmyeloablative, P = 0.27, not significant. Treo, treosulfan. (A and B) n = 15. (C) Percentage of host gut T cell chimerism determined by FISH-IF versus peripheral blood chimerism determined by STR analysis. n = 12. Broken lines indicate paired samples. Wilcoxon’s signed rank test, 2-tailed. *P = 0.01.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts